These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10688239)

  • 21. Nonhypoglycemic effects of thiazolidinediones.
    Quesada-Gómez JM; Serrano-Alferez I
    Ann Intern Med; 2001 Dec; 135(11):1007-8. PubMed ID: 11730409
    [No Abstract]   [Full Text] [Related]  

  • 22. [Glitazone--a new drug for type 2 diabetes].
    Toyota T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():422-8. PubMed ID: 12387028
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes.
    Koshiyama H; Shimono D; Kuwamura N; Minamikawa J; Nakamura Y
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3452-6. PubMed ID: 11443224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects].
    Sugiyama Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():416-21. PubMed ID: 12387027
    [No Abstract]   [Full Text] [Related]  

  • 25. Pioglitazone: cardiovascular effects in prediabetic patients.
    Mizushige K; Tsuji T; Noma T
    Cardiovasc Drug Rev; 2002; 20(4):329-40. PubMed ID: 12481203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Insulin analogs and new oral antidiabetic drugs].
    Koivisto V
    Duodecim; 1999; 115(20):2197-202. PubMed ID: 11973922
    [No Abstract]   [Full Text] [Related]  

  • 27. [Troglitazone: its pharmacology and mechanism of action].
    Horikoshi H; Fujiwara T
    Nihon Rinsho; 1997 Nov; 55 Suppl():125-30. PubMed ID: 9434455
    [No Abstract]   [Full Text] [Related]  

  • 28. Thiazolidinediones for type 2 diabetes. No evidence exists that pioglitazone induces hepatic cytochrome P450 isoform CYP3A4.
    Glazer NB; Cheatham WW
    BMJ; 2001 Jan; 322(7280):235-6. PubMed ID: 11159615
    [No Abstract]   [Full Text] [Related]  

  • 29. [When HbA1c cannot be pushed down under 7. Don't hesitate to use a 2d antidiabetic agent].
    MMW Fortschr Med; 2003 Mar; 145(10):59. PubMed ID: 12688034
    [No Abstract]   [Full Text] [Related]  

  • 30. Pioglitazone.
    Gillies PS; Dunn CJ
    Drugs; 2000 Aug; 60(2):333-43; discussion 344-5. PubMed ID: 10983737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glitazones and NIDDM.
    Sakane N; Yoshida T; Kondo M
    Lancet; 1997 Mar; 349(9056):952. PubMed ID: 9093269
    [No Abstract]   [Full Text] [Related]  

  • 32. [The efficacy and safety of pioglitazone hydrochloride in combination with sulphonylureas and metfomin in the treatment of type 2 diabetes mellitus a 12-week randomized multi-centres placebo-controlled parallel study].
    Pan C; Gao Y; Gao X; Li G; Luo B; Shi H; Tian H; Jia P; Lin H; Xing X; Zhao Y; Zhou L
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):388-92. PubMed ID: 12137601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic management of diabetes mellitus.
    Mozersky RP
    J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rosiglitazone (BRL-49653)].
    Oka Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():438-41. PubMed ID: 12387030
    [No Abstract]   [Full Text] [Related]  

  • 35. Liver failure in a patient treated with long-term rosiglitazone therapy.
    Gouda HE; Khan A; Schwartz J; Cohen RI
    Am J Med; 2001 Nov; 111(7):584-5. PubMed ID: 11705443
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA approves pioglitazone for diabetes.
    Miller JL
    Am J Health Syst Pharm; 1999 Sep; 56(17):1698. PubMed ID: 10512494
    [No Abstract]   [Full Text] [Related]  

  • 37. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug interactions--their impact on safe drug therapy in the example of the new thiazolidinedione group (glitazone)].
    Klotz U; Sailer D
    Arzneimittelforschung; 2001 Feb; 51(2):112-7. PubMed ID: 11258040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Insulin sensitizer drugs--review].
    Yamanouchi T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():409-15. PubMed ID: 12387026
    [No Abstract]   [Full Text] [Related]  

  • 40. A new era in type 2 diabetes mellitus treatment?
    Laws A
    Am J Med; 2001 Jul; 111(1):71-2. PubMed ID: 11448665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.